Literature DB >> 11740481

Pamidronate in the treatment of diffuse sclerosing osteomyelitis of the mandible.

M Soubrier1, J J Dubost, J M Ristori, B Sauvezie, J L Bussière.   

Abstract

Diffuse sclerosing osteomyelitis of the mandible is characterized by bouts of intense pain, sometimes associated with trismus and paresthesia, and leads to progressive deformity. It is of unknown etiopathology, but it is suggested to be one manifestation of the synovitis, acne, pustulosis, hyperostosis, osteomyelitis syndrome, the other features of which may have been overlooked. Treatment results are disappointing, and decortication may be necessary to achieve an acceptable outcome. We report a case restricted to the mandible that responded favorably to treatment with pamidronate. Further trials of pamidronate in patients with diffuse sclerosing osteomyelitis of the mandible, even in those with the aforementioned syndrome, are needed to assess its effectiveness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740481     DOI: 10.1067/moe.2001.119739

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  4 in total

1.  Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw.

Authors:  Dan Li; Kirill Gromov; Steven T Proulx; Chao Xie; Jie Li; Daniel P Crane; Kjeld Søballe; Regis J O'Keefe; Hani A Awad; Lianping Xing; Edward M Schwarz
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

2.  SAPHO Syndrome Diagnosis and Treatment: Report of Five Cases and Review of the Literature.

Authors:  Ch Matzaroglou; D Velissaris; A Karageorgos; M Marangos; E Panagiotopoulos; M Karanikolas
Journal:  Open Orthop J       Date:  2009-11-05

3.  Primary Chronic Osteomyelitis of the Jaws in Children: An Update on Pathophysiology, Radiological Findings, Treatment Strategies, and Prospective Analysis of Two Cases.

Authors:  Caroline Berglund; Karin Ekströmer; Jahan Abtahi
Journal:  Case Rep Dent       Date:  2015-09-07

4.  Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial.

Authors:  Stella Cecchetti; Bruno Pereira; Antoine Roche; Christophe Deschaumes; Dihya Abdi; Emmanuel Coudeyre; Jean-Jacques Dubost; Sylvain Mathieu; Sandrine Malochet-Guinamand; Anne Tournadre; Marion Couderc; Marielle Vayssade; Coline Daron; Martin Soubrier
Journal:  Trials       Date:  2014-04-09       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.